Frataxin Mitochondrial (Friedreich's Ataxia Protein or FXN or EC 1.16.3.1) - Pipeline Review, H1 2018

Publisher Name :
Date: 12-Jun-2018
No. of pages: 40

Frataxin Mitochondrial (Friedreich's Ataxia Protein or FXN or EC 1.16.3.1) - Pipeline Review, H1 2018

Summary

Frataxin Mitochondrial (Friedreich's Ataxia Protein or FXN or EC 1.16.3.1) - Frataxin is a protein encoded by the FXN gene. It promotes the biosynthesis of heme and assembly and repair of iron-sulfur clusters by delivering Fe2+ to proteins involved in these pathways. It plays a role in the protection against iron-catalyzed oxidative stress through its ability to catalyze the oxidation of Fe2+ to Fe3.

Frataxin Mitochondrial (Friedreich's Ataxia Protein or FXN or EC 1.16.3.1) pipeline Target constitutes close to 9 molecules. Out of which approximately 7 molecules are developed by companies and remaining by the universities/institutes. The molecules developed by companies in Phase II, Preclinical and Discovery stages are 2, 4 and 1 respectively. Similarly, the universities portfolio in Discovery stages comprises 2 molecules, respectively. Report covers products from therapy areas Central Nervous System and Cardiovascular which include indications Friedreich's Ataxia and Cardiomyopathy.

The latest report Frataxin Mitochondrial - Pipeline Review, H1 2018, outlays comprehensive information on the Frataxin Mitochondrial (Friedreich's Ataxia Protein or FXN or EC 1.16.3.1) targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews key players involved in Frataxin Mitochondrial (Friedreich's Ataxia Protein or FXN or EC 1.16.3.1) targeted therapeutics development with respective active and dormant or discontinued projects.

The report is built using data and information sourced from proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources.

Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.

Scope

- The report provides a snapshot of the global therapeutic landscape for Frataxin Mitochondrial (Friedreich Ataxia Protein or FXN or EC 1.16.3.1)

- The report reviews Frataxin Mitochondrial (Friedreich Ataxia Protein or FXN or EC 1.16.3.1) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources

- The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages

- The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities

- The report reviews key players involved in Frataxin Mitochondrial (Friedreich Ataxia Protein or FXN or EC 1.16.3.1) targeted therapeutics and enlists all their major and minor projects

- The report assesses Frataxin Mitochondrial (Friedreich Ataxia Protein or FXN or EC 1.16.3.1) targeted therapeutics based on mechanism of action (MoA), route of administration (RoA) and molecule type

- The report summarizes all the dormant and discontinued pipeline projects

- The report reviews latest news and deals related to Frataxin Mitochondrial (Friedreich Ataxia Protein or FXN or EC 1.16.3.1) targeted therapeutics

Reasons to buy

- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies

- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

- Identify and understand the targeted therapy areas and indications for Frataxin Mitochondrial (Friedreich Ataxia Protein or FXN or EC 1.16.3.1)

- Identify the use of drugs for target identification and drug repurposing

- Identify potential new clients or partners in the target demographic

- Develop strategic initiatives by understanding the focus areas of leading companies

- Plan mergers and acquisitions effectively by identifying key players and it's most promising pipeline therapeutics

- Devise corrective measures for pipeline projects by understanding Frataxin Mitochondrial (Friedreich Ataxia Protein or FXN or EC 1.16.3.1) development landscape

- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

Frataxin Mitochondrial (Friedreich's Ataxia Protein or FXN or EC 1.16.3.1) - Pipeline Review, H1 2018

Table of Contents
List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Frataxin Mitochondrial (Friedreich's Ataxia Protein or FXN or EC 1.16.3.1) - Overview
Frataxin Mitochondrial (Friedreich's Ataxia Protein or FXN or EC 1.16.3.1) - Therapeutics Development
Products under Development by Stage of Development
Products under Development by Therapy Area
Products under Development by Indication
Products under Development by Companies
Products under Development by Universities/Institutes
Frataxin Mitochondrial (Friedreich's Ataxia Protein or FXN or EC 1.16.3.1) - Therapeutics Assessment
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Frataxin Mitochondrial (Friedreich's Ataxia Protein or FXN or EC 1.16.3.1) - Companies Involved in Therapeutics Development
Adverum Biotechnologies Inc
Pfizer Inc
Voyager Therapeutics Inc
Frataxin Mitochondrial (Friedreich's Ataxia Protein or FXN or EC 1.16.3.1) - Drug Profiles
ADVM-063 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
AGIL-FA - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
CTI-1601 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Gene Therapy to Activate Frataxin for Friedreich's Ataxia - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Gene Therapy to Activate Frataxin for Friedreich's Ataxia - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Gene Therapy to Activate Frataxin for Friedrich's Ataxia - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
JOT-101 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Small Molecules to Activate Frataxin for Friedreich's Ataxia - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
VYFXN-01 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Frataxin Mitochondrial (Friedreich's Ataxia Protein or FXN or EC 1.16.3.1) - Dormant Products
Frataxin Mitochondrial (Friedreich's Ataxia Protein or FXN or EC 1.16.3.1) - Product Development Milestones
Featured News & Press Releases
May 18, 2018: Voyager Therapeutics Announces Additional Data at the American Society of Gene and Cell Therapy 2018 Annual Meeting
Oct 31, 2017: Agilis Biotherapeutics Announces Orphan Product Designation Approval in Europe for the Treatment of Friedreich's Ataxia
Aug 22, 2017: Jupiter Orphan Therapeutics Receives Orphan Drug Designation for its Trans-Resveratrol Product JOTROL for Treatment of Friedreich's Ataxia
Aug 03, 2017: Chondrial Announces FDA Orphan Drug Designation for CTI-1601, a Novel Investigational Technology for the Treatment of Friedreich's Ataxia
Aug 02, 2016: Agilis Biotherapeutics Announces FDA Orphan Drug Designation for the Treatment of Friedreich's Ataxia
Aug 05, 2015: Key Patent Granted for AAVLife's Gene-Therapy Program to Treat Cardiomyopathy in Friedreich's Ataxia
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer

List of Tables
Number of Products under Development by Stage of Development, H1 2018
Number of Products under Development by Therapy Areas, H1 2018
Number of Products under Development by Indication, H1 2018
Number of Products under Development by Companies, H1 2018
Products under Development by Companies, H1 2018
Number of Products under Investigation by Universities/Institutes, H1 2018
Products under Investigation by Universities/Institutes, H1 2018
Number of Products by Stage and Mechanism of Actions, H1 2018
Number of Products by Stage and Route of Administration, H1 2018
Number of Products by Stage and Molecule Type, H1 2018
Pipeline by Adverum Biotechnologies Inc, H1 2018
Pipeline by Pfizer Inc, H1 2018
Pipeline by Voyager Therapeutics Inc, H1 2018
Dormant Projects, H1 2018

List of Figures
Number of Products under Development by Stage of Development, H1 2018
Number of Products under Development by Therapy Areas, H1 2018
Number of Products under Development by Top 10 Indications, H1 2018
Number of Products by Mechanism of Actions, H1 2018
Number of Products by Stage and Mechanism of Actions, H1 2018
Number of Products by Routes of Administration, H1 2018
Number of Products by Stage and Routes of Administration, H1 2018
Number of Products by Molecule Types, H1 2018
Number of Products by Stage and Molecule Types, H1 2018
  • Global Disruptive Behavior Disorders Market Research Report 2019
    Published: 22-Mar-2019        Price: US 2900 Onwards        Pages: 98
    Disruptive Behavior Disorders is often show up against the aggressive behavior related to disease. The main cause of Disruptive Behavior Disorders presence of smoking during pregnancy or behavior disorder of family history, the growth trend of unhealthy life style also leads to Disruptive Behavior Disorders. The global Disruptive Behavior Disorders market is valued at 690 million US$ in 2018 is expected to reach 910 million US$ by the end of 2025, growing at a CAGR of 3.6% ......
  • Global Drug Blister Packaging Market Research Report 2019
    Published: 22-Mar-2019        Price: US 2900 Onwards        Pages: 104
    Drug Blister Packaging is a term for several types of pre-formed plastic packaging used for small consumer goods, foods, and for pharmaceuticals. The market for Drug Blister Packaging is expected to grow rapidly in the next few years.Drug market is an important factor influencing Drug Blister Packaging market. The global Drug Blister Packaging market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during ......
  • Global Adult Gummy Vitamin Market Research Report 2019
    Published: 22-Mar-2019        Price: US 2900 Onwards        Pages: 105
    Adult Gummy Vitamins are an enjoyable and easy way to get your daily dose of nutrients. The market for Adult Gummy Vitamin is expected to grow rapidly in the next few years.Despite the presence of competition problems, due to the clear global recovery trend, investors are still optimistic about this area, in future still more new investment will enter into the field. The global Adult Gummy Vitamin market is valued at xx million US$ in 2018 is expected to reach xx million U......
  • Global Endodontic Calcium Hydroxide Material Market Research Report 2019
    Published: 22-Mar-2019        Price: US 2900 Onwards        Pages: 93
    Calcium hydroxide is normally used as slurry of Calcium hydroxide in a water base. At body temperature less than 0.2% of Calcium hydroxide is dissolved into ca++ and OH- ions.The value of calcium hydroxide in endodontic treatment of necrotic infected teeth is now well documented. The market for Endodontic Calcium Hydroxide Material is expected to grow rapidly in the next few years. The global Endodontic Calcium Hydroxide Material market is valued at xx million US$ in 2018 i......
  • Global Custom LASIK Market Research Report 2019
    Published: 22-Mar-2019        Price: US 2900 Onwards        Pages: 109
    Custom LASIK measures the eye from front to back with a special laser, using "wavefront" technology, to create a three-dimensional image of the eye. In the next few years, Custom LASIK industry will still be a relative highly energetic industry.USA has the largest global export quantity and manufacturers in Custom LASIK market, while the Europe is the second sales volume market for Custom LASIK in 2017. The global Custom LASIK market is valued at xx million US$ in 2018 is ......
  • Global Carbohydrate Supplements Market Research Report 2019
    Published: 22-Mar-2019        Price: US 2900 Onwards        Pages: 98
    Carbohydrate Supplements are also known in biochemistry as saccharides. The saccharides are then divided into four chemical grouping: monosaccharides, disaccharides, oligosaccharides, and polysaccharides. In the next few years, Carbohydrate Supplements will still be a relative highly energetic industry. The major drivers include the rising awareness among people, regarding health concerns, and the growing preference for supplements, which are convenient to maintain fitness. ......
  • Global Test Boosters Market Research Report 2019
    Published: 22-Mar-2019        Price: US 2900 Onwards        Pages: 107
    Natural test boosters claim to stimulate your body to produce more testosterone to support muscle growth. In the next few years, Test Boosters industry will still be a relative highly energetic industry. The major drivers include the rising awareness among people, regarding health concerns, and the growing preference for supplements, which are convenient to maintain fitness. The global Test Boosters market is valued at xx million US$ in 2018 is expected to reach xx million ......
  • Global Weight Gain Supplements Market Research Report 2019
    Published: 22-Mar-2019        Price: US 2900 Onwards        Pages: 106
    Weight Gain Supplements can help you develop size and look fuller. In the next few years, Weight Gain Supplements industry will still be a relative highly energetic industry. The major drivers include the rising awareness among people, regarding health concerns, and the growing preference for supplements, which are convenient to maintain fitness. The global Weight Gain Supplements market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2......
  • Global Trial Size Supplements Market Research Report 2019
    Published: 22-Mar-2019        Price: US 2900 Onwards        Pages: 91
    Trial Size Supplements refers to travel size packages of vitamins and other dietary supplements. In the next few years, Trial Size Supplements industry will still be a relative highly energetic industry. The major drivers include the rising awareness among people, regarding health concerns, and the growing preference for supplements, which are convenient to maintain fitness. The global Trial Size Supplements market is valued at xx million US$ in 2018 is expected to reach xx......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs